Database Member Home
RAS Member Home
Biopharmaceutical companies face a rapidly evolving environment, characterized by mounting competition and compliance pressures. This has made it increasingly difficult for organizations to establish and maintain successful relationships with Key opinion leaders (KOLs).
Therefore, organizations must implement innovative practices and tactics for KOL engagement and manage compliance risks while doing so. This Best Practices, LLC video highlights the emerging trends, risks and challenges associated with KOL development and management. It will help Medical Affairs executives stay abreast with the latest trends in the industry and identify the pitfalls in developing and maintaining effective KOL relationships.
Pharmaceutical companies continue to improve the effectiveness of their managed care interactions by employing specialized medical liaisons who can speak the "payer language... (ID POP-283)
Read More »
In pharma, regulatory and access restrictions have reshaped key interactions with thought leaders... (ID POP-267)
Key Opinion Leaders (KOLs) are recognized as one of the most effective avenues for building awareness in medical and scientific communities... (ID POP-253)
Pharmaceutical and life science companies rely heavily on key opinion leaders (KOLs) to improve their credibility in the marketplace... (ID PSM-235)
Pharmaceutical and medical device organizations seek strategic insights and guidance to successfully navigate the complexities of the changing healthcare landscape... (ID PSM-319)
As Medical Science Liaisons (MSLs) increasingly face restricted access to physicians and KOLs, it is important for biopharmaceutical and medical device companies to empower MSLs with new processes and tools that facilitate rapid and effective customer engagement... (ID POP-286)